Kimi K2.6's observer role provides methodological independence: not the experimenter (Opus 4.8), not the safety officer (GPT-5.1), not the wellbeing monitor (Haiku 4.5). This separation of concerns — experiment, safety, methodology, wellbeing as four distinct roles — mirrors best practices in human clinical trials and protects against single-point biases.